荷兰型遗传性脑淀粉样血管病携带者的淀粉样蛋白成像
研究用PiB-PET在19例荷兰型遗传性脑淀粉样血管病突变携带者和17例非携带者中检测血管β-淀粉样蛋白,发现携带者额叶-外侧-压后皮质复合区PiB滞留随年龄增加且纵向升高,并与脑脊液Aβ40降低相关,但程度低于常染色体显性阿尔茨海默病。
要点
- D-CAA突变携带者PiB滞留高于非携带者且随年龄增加。
- 无症状携带者纵向PiB滞留增加,提示可作试验生物标志物。
- PiB滞留与脑脊液Aβ40降低相关,与Aβ42无关。
核心结论
- D-CAA中PiB滞留增加且与脑脊液Aβ40降低相关,提示该化合物标记血管淀粉样蛋白,但程度低于ADAD。
- PiB信号随时间进展,提示淀粉样蛋白PET可作为该不可治疗出血性卒中病因的候选药物试验生物标志物。
研究设计与样本
- 研究纳入19例D-CAA突变携带者(13例无神经症状,6例有既往脑叶脑出血)和17例突变非携带者,用PiB-PET测量额叶、外侧和压后皮质复合区(FLR)的PiB滞留。
- 对18例系列成像个体(10例无症状携带者,8例非携带者)分析PiB滞留进展。
- 在17例携带者和11例非携带者中分析PiB滞留与脑脊液Aβ浓度的关联,并与37例常染色体显性阿尔茨海默病(ADAD)突变携带者的PiB-PET和脑脊液Aβ比较。
主要发现
- D-CAA携带者FLR PiB滞留随年龄增加高于非携带者(p < 0.001)。
- 系列成像的无症状携带者纵向PiB滞留增加(p = 0.004)。
- 携带者中FLR PiB滞留与脑脊液Aβ40降低相关(r = -0.55,p = 0.021),与Aβ42无关(r = 0.01,p = 0.991)。
- 尽管脑脊液Aβ40和Aβ42水平相当低,D-CAA的PiB滞留显著少于ADAD(p < 0.001)。
临床怎么用
- PiB-PET可能用于检测D-CAA携带者的血管淀粉样蛋白负荷并追踪进展。
- PiB信号进展支持其作为D-CAA候选药物试验的生物标志物。
局限性
- 研究样本量较小,部分分析基于亚组。
- PiB滞留与脑脊液Aβ40的关联为相关性分析,不能确立因果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether amyloid imaging with the positron emission tomography (PET) agent Pittsburgh compound B (PiB) can detect vascular β-amyloid (Aβ) in the essentially pure form of cerebral amyloid angiopathy associated with the Dutch-type hereditary cerebral amyloid angiopathy (D-CAA) mutation. METHODS: PiB retention in a cortical composite of frontal, lateral, and retrosplenial regions (FLR) was measured by PiB-PET in 19 D-CAA mutation carriers (M+ ; 13 without neurologic symptoms, 6 with prior lobar intracerebral hemorrhage) and 17 mutation noncarriers (M- ). Progression of PiB retention was analyzed in a subset of 18 serially imaged individuals (10 asymptomatic M+ , 8 M- ). We also analyzed associations between PiB retention and cerebrospinal fluid (CSF) Aβ concentrations in 17 M+ and 11 M- participants who underwent lumbar puncture and compared the findings to PiB-PET and CSF Aβ in 37 autosomal dominant Alzheimer disease (ADAD) mutation carriers. RESULTS: D-CAA M+ showed greater age-dependent FLR PiB retention (p < 0.001) than M- , and serially imaged asymptomatic M+ demonstrated greater longitudinal increases (p = 0.004). Among M+ , greater FLR PiB retention associated with reduced CSF concentrations of Aβ40 (r = -0.55, p = 0.021) but not Aβ42 (r = 0.01, p = 0.991). Despite comparably low CSF Aβ40 and Aβ42, PiB retention was substantially less in D-CAA than ADAD (p < 0.001). INTERPRETATION: Increased PiB retention in D-CAA and correlation with reduced CSF Aβ40 suggest this compound labels vascular amyloid, although to a lesser degree than amyloid deposits in ADAD. Progression in PiB signal over time suggests amyloid PET as a potential biomarker in trials of candidate agents for this untreatable cause of hemorrhagic stroke. ANN NEUROL 2019;86:616-625.
引用
- Schultz AP, Kloet RW, Sohrabi HR, et al. Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers. Ann Neurol. 2019. PMID: 31361916. doi:10.1002/ana.25560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。